Å×¶ó³ë½ºÆ½½º ½ÃÀå : Ä¡·á ºÐ¾ßº°, ±â¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Theranostics Market, By Therapeutic Area, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1498764
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 325 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,702,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,728,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,174,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Å×¶ó³ë½ºÆ½½º ½ÃÀå ±Ô¸ð´Â 2023³â 23¾ï 9,020¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2024³âºÎÅÍ 2032³â±îÁö 13.90%ÀÇ CAGR·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Å×¶ó³ë½ºÆ½½º ½ÃÀå - ½ÃÀå ¿ªÇÐ

Å×¶ó³ë½ºÆ½½º ½ÃÀåÀ» ÁÖµµÇÏ´Â Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ´ë

Á¤¹ÐÀÇ·á Á¢±Ù¹ýÀº Á¾¾çÇÐ, ½Å°æÇÐ, ¼øÈ¯±âÇÐ, Àü¿°º´ µî ´Ù¾çÇÑ ÀÇ·á ºÐ¾ß¿¡¼­ ÁÖ¸ñÀ» ¹Þ°í ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ¿¡ µû¸£¸é, 2022³â Àü ¼¼°è Á¤¹ÐÀÇ·á Ä¡·á ºñ¿ëÀº ¾à 3200¾ï ´Þ·¯¿¡ ´ÞÇßÀ¸¸ç, 2027³â¿¡´Â ¾à 1240¾ï ´Þ·¯·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯ÀüüÇÐ, ÇÁ·ÎÅ׿À¹Í½º ¹× ±âŸ ¿À¹Í½º ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÇ·áÁøÀº Áúº´ÀÇ ±Ùº»ÀûÀÎ ºÐÀÚ ¸ÞÄ¿´ÏÁòÀ» ´õ ±íÀÌ ÀÌÇØÇϰí Ä¡·á È¿°ú¸¦ ¿¹ÃøÇÒ ¼ö ÀÖ´Â ¹ÙÀÌ¿À¸¶Ä¿¸¦ ½Äº°ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î, Æó¾Ï¿¡ ´ëÇÑ Á¤¹Ð ÀÇÇÐÀÇ ¹ßÀüµÈ ¸ðµ¨ÀÎ Å×¶ó³ë½ºÆ½½º´Â ȯÀÚ °³°³ÀÎÀÇ Æ¯¼º¿¡ ´ëÀÀÇϱâ À§ÇØ °³º° ¶Ç´Â ´ë»ó Áý´ÜÀÇ Áúº´ ¿¹¹æ, Áø´Ü ¹× Ä¡·á¸¦ °áÇÕÇÏ¿© Ä¡·áÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÓ»óÀû Ư¼º ¿Ü¿¡µµ Æó¾Ï ȯÀÚÀÇ °Ô³ð, Àü»çü, ÇÁ·ÎÅ׿È, ´ë»çü Ư¼ºÀ» ¼öÁýÇϰí ÅëÇÕÇÏ´Â °ÍÀÌ ÇÊ¿äÇÕ´Ï´Ù.

Å×¶ó³ë½ºÆ½½º ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032) µ¿¾È ¸Å³â ¾à 13.90%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Ä¡·á ºÐ¾ß ¼¼ºÐÈ­¿¡ µû¶ó Á¾¾çÇÐÀÌ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÆ½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚ ¼¼ºÐÈ­¿¡ µû¸£¸é, 2023³â¿¡´Â º´¿ø°ú Ŭ¸®´ÐÀÌ ÁÖ¿ä À¯ÇüÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¸ÅÃâ¿¡¼­ ¼±µÎ¸¦ Â÷ÁöÇß½À´Ï´Ù.

Å×¶ó³ë½ºÆ½½º ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®:

Å×¶ó³ë½ºÆ½½º ¼¼°è ½ÃÀåÀº Ä¡·á ¿µ¿ª, ±â¼ú, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾»ç¿ëÀÚ¿¡ µû¶ó º´¿ø ¹× Ŭ¸®´Ð, Áø´Ü ¿¬±¸¼Ò, ±âŸÀÇ ¼¼ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. Áúº´°ú °ü·ÃµÈ ƯÁ¤ ºÐÀÚ Ç¥ÀûÀ» ½Äº°ÇÔÀ¸·Î½á Å×¶ó³ë½ºÆ½½º´Â Ç¥Àû Ä¡·áÀÇ Á¦°øÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ Á¢±Ù ¹æ½ÄÀº Ä¡·áÀÇ Á¤È®¼º°ú È¿´ÉÀ» ³ôÀÌ°í °Ç°­ÇÑ Á¶Á÷¿¡ ´ëÇÑ ºÎ¼öÀûÀÎ ¼Õ»óÀ» ÁÙÀÔ´Ï´Ù. ¸¹Àº Å×¶ó³ë½ºÆ½½º ±â¼úÀº ±âÁ¸ ÀÇ·á ÀÎÇÁ¶ó¿¡ ¿øÈ°ÇÏ°Ô ÅëÇÕµÉ ¼ö Àֱ⠶§¹®¿¡ ȯÀÚ³ª ÀÓ»óÀǰ¡ Ãß°¡ÀûÀÎ ÀÚ¿øÀ̳ª ÀÎÇÁ¶ó¸¦ Ãß°¡ÇÏÁö ¾Ê°íµµ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀåÀº Ä¡·á ¿µ¿ª¿¡ µû¶ó ½Å°æ Áúȯ, ¸é¿ª Áúȯ, ¼øÈ¯±â Áúȯ, ¾Ï, ±âŸ Áúȯ µî 5°¡Áö Ä«Å×°í¸®·Î ºÐ·ùµË´Ï´Ù. Æó¾Ï, ÀڱðæºÎ¾Ï, ´ëÀå¾Ï, À¯¹æ¾Ï ¹× ±âŸ ¾ÏÀº ¾Ï ¿µ¿ªÀÇ ¼½¼Ç¿¡¼­ ´õ¿í ¼¼ºÐÈ­µË´Ï´Ù. ¾Ï ºÐ¾ß°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È °è¼Ó ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â Å×¶ó³ë½ºÆ½½º°¡ ¾Ï Ä¡·á¿¡¼­ Ä¡·á Áö¿¬À» ÁÙÀ̰í, Ä¡·á °úÁ¤ÀÇ ¸¹Àº ´Ü°è¸¦ »ý·«Çϰí, ȯÀÚ Ä¡·á¸¦ °­È­Çϱâ À§ÇØ ¾Ï Ä¡·á¿¡ ´õ ³Î¸® »ç¿ëµÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù.

Å×¶ó³ë½ºÆ½½º ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

ºÏ¹Ì´Â źźÇÑ ÀÇ·á ½Ã½ºÅÛ, °­·ÂÇÑ ¿¬±¸ ±â°ü, À¯¸®ÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©·Î ÀÎÇØ ¼¼¶ó³ë½ºÆ½ÀÇ ¹ßÀüÀ» ÁÖµµÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ƯÈ÷ ¹Ì±¹Àº Å×¶ó³ë½ºÆ½½º °³¹ß ¹× µµÀÔ¿¡ ÀÖ¾î ¿©·¯ ÁÖ¿ä ±â¾÷µéÀÌ ÀÖ½À´Ï´Ù. ºÏ¹Ì¿¡´Â Å×¶ó³ë½ºÆ½½º ¿¬±¸°³¹ß¿¡ Àû±ØÀûÀ¸·Î Âü¿©Çϰí ÀÖ´Â ´ëÇü Á¦¾à»çµéÀÌ ´Ù¼ö Á¸ÀçÇÕ´Ï´Ù. ÀÌµé ±â¾÷Àº Å×¶ó³ë½ºÆ½½º Á¦Ç°ÀÇ »ó¿ëÈ­¸¦ °¡¼ÓÈ­ÇÏ°í ½ÃÀå¿¡ Ãâ½ÃÇÒ ¼ö ÀÖ´Â ÀÚ¿ø°ú Àü¹®¼ºÀ» º¸À¯Çϰí ÀÖ½À´Ï´Ù. Áß±¹, Àεµ, Çѱ¹°ú °°Àº ½ÅÈï±¹Àº ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡, Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡·Î ÀÎÇØ Å×¶ó³ë½ºÆ½½ºÀÇ ±Þ¼ÓÇÑ ¼ºÀåÀ» ¸ñ°ÝÇϰí ÀÖ½À´Ï´Ù.

Å×¶ó³ë½ºÆ½½º ½ÃÀå - °æÀï »óȲ:

¿µ»ó Áø´Ü ±â¼úÀ» Àü¹®À¸·Î ÇÏ´Â ±â¾÷µéµµ Å×¶ó³ë½ºÆ½½º ½ÃÀå¿¡¼­ °æÀïÇϰí ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷Àº Áúº´À» Áø´ÜÇÏ°í ¸ð´ÏÅ͸µÇÏ´Â µ¥ »ç¿ëµÇ´Â ¿µ»ó ¾à¹°°ú ±â¼úÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î GEÇコÄɾî, Áö¸à½º ÇïÆ¼´Ï¾î½º, Çʸ³½º ÇコÄÉ¾î µîÀÌ ÀÖ½À´Ï´Ù. ¹æ»ç¼ºÀǾàǰ ±â¾÷µéÀº ¼¼¶ó³ë½ºÆ½¿¡ »ç¿ëµÇ´Â ¹æ»ç¼ºÀǾàǰÀÇ °³¹ß°ú »ý»ê¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷Àº ¾ÏÀ» ºñ·ÔÇÑ ´Ù¾çÇÑ Áúº´¿¡ ´ëÇÑ Ç¥Àû Ä¡·áÁ¦¸¦ Á¦°øÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Å×¶ó³ë½ºÆ½½º ½ÃÀå¿¡¼­´Â Á¦¾àȸ»ç, Áø´Üȸ»ç, ¿¬±¸±â°ü µî ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚµéÀÌ Çù·ÂÇÏ´Â °ÍÀÌ ÀϹÝÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÆÄÆ®³Ê½ÊÀº »óÈ£º¸¿ÏÀûÀÎ Àü¹® Áö½Ä°ú ÀÚ¿øÀ» Ȱ¿ëÇÏ¿© ¼¼¶ó¹Í Á¦Ç° °³¹ß ¹× »ó¿ëÈ­¸¦ ÃËÁøÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, bioMerieux´Â ±Û¶ô¼Ò ½º¹Ì½ºÅ¬¶óÀÎ(GlaxoSmithKline)°ú °è¾àÀ» ü°áÇÏ¿© ÀÓ»óÀǰ¡ À¯¹æ¾Ï ȯÀÚÀÇ ´Ù¾çÇÑ ºÎ·ù¿¡ °¡Àå ÀûÇÕÇÑ Ä¡·á¹ýÀ» ¼±ÅÃÇÒ ¼ö ÀÖµµ·Ï ¿¹Ãø °Ë»ç¸¦ °³¹ßÇϱâ·Î Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Å×¶ó³ë½ºÆ½½º ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Å×¶ó³ë½ºÆ½½ºÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå Å×¶ó³ë½ºÆ½½º »ê¾÷ ¿¬±¸

Á¦5Àå Å×¶ó³ë½ºÆ½½º ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå Å×¶ó³ë½ºÆ½½º ½ÃÀå »óȲ

Á¦7Àå Å×¶ó³ë½ºÆ½½º ½ÃÀå : Ä¡·á ºÐ¾ßº°

Á¦8Àå Å×¶ó³ë½ºÆ½½º ½ÃÀå : ±â¼úº°

Á¦9Àå Å×¶ó³ë½ºÆ½½º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå Å×¶ó³ë½ºÆ½½º ½ÃÀå : Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® : Å×¶ó³ë½ºÆ½½º ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Theranostics Market size was valued at USD 2,390.20 million in 2023, expanding at a CAGR of 13.90% from 2024 to 2032.

The theranostics market involves the combination of diagnostics with therapeutics to create personalized treatment plans for patients. This approach allows for tailored therapy based on an individual's specific genetic makeup, disease state, and other relevant factors. The key drivers of the theranostics market are the growing focus on personalized medicine and precision healthcare. By using diagnostic tests to identify biomarkers or specific molecular targets, healthcare providers can better match patients with the most effective treatments, potentially improving outcomes and reducing adverse effects. Furthermore, the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, has fueled the demand for innovative therapeutic approaches.

Theranostics Market- Market Dynamics

Increasing focus on precision medicines propelling the theranostics market

Precision medicine approaches have gained traction across various medical fields, including oncology, neurology, cardiology, and infectious diseases. As per data, in 2022, total spending on treatments with precision medicine stood at some 32 billion U.S. dollars globally. By 2027, it is projected that total spending will increase to around 124 billion dollars. With advancements in genomics, proteomics, and other omics technologies, healthcare providers can better understand the molecular mechanisms underlying diseases and identify biomarkers that help predict treatment response. Forr instance, Theranostics, an advanced model of precision medicine for lung cancer, combines prevention, diagnosis, and treatment for individual or targeted population disorders to accommodate individual patient characteristics. In addition to clinical traits, it entails gathering and integrating lung cancer patient's genome, transcriptome, proteome, and metabolome properties.

Theranostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 13.90% over the forecast period (2024-2032)

Based on Therapeutic Area segmentation, oncology was predicted to show maximum market share in the year 2023

Based on end-user segmentation, Hospitals, and Clinics was the leading type in 2023

based on region, North America was the leading revenue generator in 2023

Theranostics Market- Segmentation Analysis:

The Global Theranostics Market is segmented on the basis of Therupatic Area, Technology, End User, and Region.

The market is divided into three categories based on end-users: Hospitals and Clinics, Diagnostic Laboratories, and Others. By identifying specific molecular targets associated with diseases, theranostics facilitates targeted therapy delivery. This approach enhances treatment precision, and effectiveness, and reduces collateral damage to healthy tissues. Many theranostic techniques can be seamlessly integrated into existing healthcare infrastructure, making them readily accessible to patients and clinicians without requiring significant additional resources or infrastructure.

The market is divided into five categories based on therapeutic area: Neurological conditions, immunological disorders, cardiovascular illnesses, oncology, and other conditions. Lung cancer, cervical cancer, colorectal cancer, breast cancer, and other cancers are further subdivided under the oncology section. The market was led by the oncology segment, which is anticipated to continue leading during the projection period. This is because theranostics is becoming more widely used in cancer therapy to reduce treatment delays, eliminate many steps in the process, and enhance patient care.

Theranostics Market- Geographical Insights

North America region often leads in theranostics advancements due to well-established healthcare systems, strong research institutions, and favorable regulatory frameworks. The United States, in particular, hosts several key players in theranostics development and adoption. North America is home to many leading pharmaceutical companies that are actively involved in theranostics research and development. These companies have the resources and expertise to accelerate the commercialization of theranostic products and bring them to market. Emerging economies like China, India, and South Korea are witnessing rapid growth in theranostics due to increasing investments in healthcare infrastructure, rising prevalence of chronic diseases, and a growing emphasis on precision medicine.

Theranostics Market- Competitive Landscape:

Companies specializing in diagnostic imaging technologies also compete in the theranostics market. They develop imaging agents and technologies used for the diagnosis and monitoring of diseases. Examples include GE Healthcare, Siemens Healthineers, and Philips Healthcare. Radiopharmaceutical companies focus on the development and production of radiopharmaceuticals used in theranostics. These companies play a crucial role in providing targeted therapies for various diseases such as cancer. Collaboration between different stakeholders such as pharmaceutical companies, diagnostic companies, and research institutions is common in the theranostics market. These partnerships facilitate the development and commercialization of theranostic products by leveraging complementary expertise and resources. For instance, bioMerieux has signed an agreement with GlaxoSmithKline to develop a predictive test to help clinicians select the most appropriate treatment for different segments of breast cancer patients.

Recent Developments:

In June 2023, The ICPO Foundation and FMRI recently revealed a reference center cooperation that will foster global standards of education in Radiomolecular Precision Oncology (RPO) and assist in setting up novel Theranostics Centres in India.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERANOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific Inc.

AmeriPath, Inc.

Beckman Coulter, Inc.

Foundation Medicine, Inc.

Hoffmann-La Roche Ltd

Myriad Genetics, Inc.

Focus Diagnostics

Abbott Laboratories

Illumina, Inc.

QIAGEN

Agilent Technologies, Inc.

Others

GLOBAL THERANOSTICS MARKET, BY THERUPATIC AREA - MARKET ANALYSIS, 2019 - 2032

GLOBAL THERANOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

GLOBAL THERANOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL THERANOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Theranostics Market Overview

2. Executive Summary

3. Theranostics Key Market Trends

4. Theranostics Industry Study

5. Theranostics Market: COVID-19 Impact Analysis

6. Theranostics Market Landscape

7. Theranostics Market - By Therupatic Area

8. Theranostics Market - By Technology

9. Theranostics Market - By End User

10. Theranostics Market- By Geography

11. Key Vendor Analysis- Theranostics Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â